BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31322692)

  • 1. Deep Learning to Assess Long-term Mortality From Chest Radiographs.
    Lu MT; Ivanov A; Mayrhofer T; Hosny A; Aerts HJWL; Hoffmann U
    JAMA Netw Open; 2019 Jul; 2(7):e197416. PubMed ID: 31322692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.
    Lu MT; Raghu VK; Mayrhofer T; Aerts HJWL; Hoffmann U
    Ann Intern Med; 2020 Nov; 173(9):704-713. PubMed ID: 32866413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs.
    Yoo H; Kim KH; Singh R; Digumarthy SR; Kalra MK
    JAMA Netw Open; 2020 Sep; 3(9):e2017135. PubMed ID: 32970157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Learning to Estimate Biological Age From Chest Radiographs.
    Raghu VK; Weiss J; Hoffmann U; Aerts HJWL; Lu MT
    JACC Cardiovasc Imaging; 2021 Nov; 14(11):2226-2236. PubMed ID: 33744131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.
    Tammemägi MC; Church TR; Hocking WG; Silvestri GA; Kvale PA; Riley TL; Commins J; Berg CD
    PLoS Med; 2014 Dec; 11(12):e1001764. PubMed ID: 25460915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.
    Oken MM; Hocking WG; Kvale PA; Andriole GL; Buys SS; Church TR; Crawford ED; Fouad MN; Isaacs C; Reding DJ; Weissfeld JL; Yokochi LA; O'Brien B; Ragard LR; Rathmell JM; Riley TL; Wright P; Caparaso N; Hu P; Izmirlian G; Pinsky PF; Prorok PC; Kramer BS; Miller AB; Gohagan JK; Berg CD;
    JAMA; 2011 Nov; 306(17):1865-73. PubMed ID: 22031728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
    Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
    PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.
    Lotan Y; Karam JA; Shariat SF; Gupta A; Roupret M; Bensalah K; Margulis V
    Urol Oncol; 2016 Apr; 34(4):167.e9-16. PubMed ID: 26602092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality.
    Prosper AE; Inoue K; Brown K; Bui AAT; Aberle D; Hsu W
    JAMA Netw Open; 2021 Aug; 4(8):e2119629. PubMed ID: 34427681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes: A Secondary Analysis of the PLCO Cancer Screening Trial.
    Pierre-Victor D; Pinsky PF
    JAMA Intern Med; 2019 Feb; 179(2):196-203. PubMed ID: 30592477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Lung Cancer Screening Strategies in a Nationally Representative US Population Using Transportability Methods for the National Lung Cancer Screening Trial.
    Robertson SE; Joyce NR; Steingrimsson JA; Stuart EA; Aberle DR; Gatsonis CA; Dahabreh IJ
    JAMA Netw Open; 2024 Jan; 7(1):e2346295. PubMed ID: 38289605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection criteria for lung-cancer screening.
    Tammemägi MC; Katki HA; Hocking WG; Church TR; Caporaso N; Kvale PA; Chaturvedi AK; Silvestri GA; Riley TL; Commins J; Berg CD
    N Engl J Med; 2013 Feb; 368(8):728-36. PubMed ID: 23425165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
    Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
    JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.
    Meza R; ten Haaf K; Kong CY; Erdogan A; Black WC; Tammemagi MC; Choi SE; Jeon J; Han SS; Munshi V; van Rosmalen J; Pinsky P; McMahon PM; de Koning HJ; Feuer EJ; Hazelton WD; Plevritis SK
    Cancer; 2014 Jun; 120(11):1713-24. PubMed ID: 24577803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort.
    Krabbe LM; Svatek RS; Shariat SF; Messing E; Lotan Y
    Urol Oncol; 2015 Feb; 33(2):65.e19-25. PubMed ID: 25044253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
    Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
    PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
    Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
    EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiologists can visually predict mortality risk based on the gestalt of chest radiographs comparable to a deep learning network.
    Weiss J; Taron J; Jin Z; Mayrhofer T; Aerts HJWL; Lu MT; Hoffmann U
    Sci Rep; 2021 Oct; 11(1):19586. PubMed ID: 34599265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities on chest radiograph reported in subjects in a cancer screening trial.
    Pinsky PF; Freedman M; Kvale P; Oken M; Caporaso N; Gohagan J
    Chest; 2006 Sep; 130(3):688-93. PubMed ID: 16963664
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.